Diagnostic and Interventional Cardiology

This study aims to compare the GORE VIABAHN VBX Balloon Expandable Endoprosthesis primary patency to bare metal stenting to evaluate superiority in treating complex iliac occlusive disease with the goal of informing practice guidelines around which modality is best suited for patients with this condition

First Patients Enrolled in the Gore VBX Forward Clinical Study

January 19, 2024 — W. L. Gore & Associates, Inc. announced that the first patients have been enrolled in the Gore VBX ...

January 19, 2024

Sumeet Chugh, MD, shown at work in his Cedars-Sinai laboratory

News | Sudden Cardiac Arrest

Smidt Heart Institute Sudden Cardiac Arrest Expert Receives 2024 Distinguished Scientist Award

January 19, 2024 — Heart rhythm expert Sumeet Chugh, MD, associate director of the Smidt Heart Institute at Cedars-Sinai ...

January 19, 2024

Abbott's Volt PFA System is designed to overcome limitations of first-generation PFA systems by providing physicians a clearer indication of contact between the Volt PFA Catheter and targeted tissue

News | Atrial Fibrillation

Abbott Announces First Global Procedures in a Clinical Trial of its Volt Pulsed Field Ablation System to Treat Patients with Abnormal Heart Rhythms

January 18, 2024 — Abbott announced the first global procedures have been conducted using the company's new Volt Pulsed ...

January 18, 2024

Sponsored Content

ASCEND provides the tools that not only address the unique needs of each cardiovascular subspecialty and to care for patients from infancy into their golden years, they also innovates next-generation solutions and services that empower the provider community to truly transform their cardiovascular services

Feature | Information Technology

SPONSORED CONTENT: Unveiling the Future of Cardiovascular Workflow

Providing exceptional cardiovascular care for patients to achieve the best possible outcomes is the number one goal for ...

March 21, 2024

First in-man experience exceeds expectations, cited as “game changer” for below-the-knee procedures

News | Balloon Catheter

Injectable Angioplasty Balloon Catheter Transforms Peripheral Procedures, Users Report Reduced Equipment and Contrast Needs

January 18, 2024 — Summa Therapeutics, LLC announced that the first-in-man injectable angioplasty procedures for ...

January 18, 2024

The American Heart Association has issued a new Policy Statement focused on the need to address structural racism as a central component to reducing cardiovascular disparities across the United States.

News | AHA

American Heart Association New Policy Statement: Addressing Structural Racism Central to Reducing U.S. Cardiovascular Disease Disparities

January 18, 2024 — A new American Heart Association (AHA) policy statement examines the history of structural racism ...

January 18, 2024

Physician-researcher David Ouyang, MD, to bring longstanding expertise to Journal focused on artificial intelligence and machine learning

News | Artificial Intelligence

Smidt Heart Institute Expert Named Deputy Editor of NEJM AI

January 17, 2024 — One of the Smidt Heart Institute’s leading experts in artificial intelligence, David Ouyang, MD, has ...

January 17, 2024

Sponsored Content

Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability to diagnose cardiac disease with greater accuracy and precision

Feature | Cardiac Imaging

SPONSORED CONTENT: Finding the Right Solution

Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability ...

March 05, 2024

The application of AI technology in the diagnosis of cardiovascular diseases using coronary CT angiography (CCTA) has gradually deepened

News | Artificial Intelligence

Artificial Intelligence Helps Coronary CT Angiography and Accelerates the Development of Precision Medicine

January 17, 2024 — This review was jointly published by Prof. Long-Jiang Zhang (Department of Radiology, Jinling ...

January 17, 2024

Satya Shreenivas, MD, MBA has joined the company as Chief Medical Officer.

News | Heart Failure

Cardiac Dimensions Appoints Satya Shreenivas, MD, as Chief Medical Officer

January 16, 2024 — Cardiac Dimensions, a leader in the development of innovative and minimally invasive treatment ...

January 16, 2024

Pilot program to deploy highly portable technology to be rolled out later this year

News | Artificial Intelligence

Novel AI Platform Matches Cardiologists in Detecting Rheumatic Heart Disease

January 16, 2024 — Artificial intelligence (AI) has the potential to detect rheumatic heart disease (RHD) with the same ...

January 16, 2024

Sponsored Content

Blog

BLOG: Combining Local Impedance with Contact Force to Perform RF Ablation

When performing radiofrequency (RF) ablation to treat cardiac arrhythmia, medical professionals must balance the safety ...

December 11, 2023

Latest technology combines superior catheter design and sustained aspiration to maximize blood clot removal from the coronary vasculature

News | Thrombectomy Devices

Penumbra Launches Indigo System CAT RX Catheter in Europe to Address Acute Coronary Syndrome

January 16, 2024 — Penumbra, Inc., a thrombectomy company, has recently secured CE Mark (Conformité Européenne) for its ...

January 16, 2024

News | Cardiovascular Education

Cardiac Safety Research Consortium Announces Think Tank Program with FDA Regulators, Industry and Academia Focused on Cardiac Remote Monitoring Trials and AI

January 15, 2024 — A public-private partnership Think Tank, scheduled for Feb. 29-March 1, will be presented by the ...

January 15, 2024

Ultromics, a patient outcomes-focused AI-driven health technology company with roots at the University of Oxford, UK, has entered into an agreement with Pfizer to support the validation and FDA clearance of its AI-based technology for the detection of cardiac amyloidosis.

News | Artificial Intelligence

Ultromics Announces Partnership to Expedite Development of Echo AI Algorithm for Early Detection of Cardiac Amyloidosis

January 15, 2024 — Ultromics, a patient outcomes-focused AI-driven health technology company with roots at the ...

January 15, 2024

Sponsored Content

Case Study | Hemodynamic Monitoring Systems

TECH BRIEF — Integrated Hemodynamic Monitoring System Helps Improve Lab Performance, Efficiency

Change Healthcare Cardiology Hemodynamics is an integrated hemodynamic monitoring system for monitoring vital signs and ...

November 14, 2023

Larry Goldstein, M.D., chair of the University of Kentucky Department of Neurology.

News | Stroke

Goldstein Selected to Help Lead Statewide Task Force Addressing Heart Disease and Stroke

January 15, 2024 — Larry Goldstein, M.D., chair of the University of Kentucky Department of Neurology, has been selected ...

January 15, 2024

Webinar addresses driving efficiency while maintaining diagnostic performance.

News | Computed Tomography (CT)

SPONSORED CONTENT: Webinar on Applying SMART-CT Results to Daily Clinical Practice

HeartFlow is offering a free webinar based on a recent study that measured the ability of the of its roadmap analysis to ...

January 15, 2024

ATTRibute-CM demonstrated a significant treatment effect of acoramidis on the primary endpoint (a hierarchical analysis inclusive of all-cause mortality (ACM) and frequency of cardiovascular-related hospitalization (CVH)), with a Win Ratio of 1.8 (p<0.0001)

News | Pharmaceuticals

BridgeBio Pharma Announces Publication of Positive Results from Phase 3 ATTRibute-CM Study of Acoramidis for Patients with Transthyretin Amyloid Cardiomyopathy (ATTR-CM) in the New England Journal of Medicine

January 12, 2024 — BridgeBio Pharma, Inc., a commercial-stage biopharmaceutical company focused on genetic diseases and ...

January 12, 2024